Progyny Inc
(PGNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 46,035 | 32,171 | 15,059 | 54,336 | 43,804 |
| Depreciation Amortization | 3,149 | 2,313 | 1,108 | 1,060 | -1,452 |
| Income taxes - deferred | 31 | 23 | 11 | -10,456 | 10,351 |
| Accounts receivable | -32,155 | -47,166 | -69,732 | -9,874 | -51,579 |
| Accounts payable and accrued liabilities | 27,660 | 45,207 | 49,618 | -30,268 | 5,072 |
| Other Working Capital | -5,997 | -5,207 | -5,726 | -11,775 | -35,767 |
| Other Operating Activity | 117,266 | 77,977 | 59,470 | 186,082 | 156,512 |
| Operating Cash Flow | $155,989 | $105,318 | $49,808 | $179,105 | $126,941 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -311,513 | -200,088 | -145,809 | -170,339 | -170,339 |
| PPE Investments | -12,796 | -8,112 | -2,843 | -5,405 | -3,510 |
| Net Acquisitions | -9,340 | -9,340 | -9,340 | -5,304 | -5,304 |
| Sale Of Investment | 166,380 | 93,015 | 63,382 | 376,840 | 299,955 |
| Investing Cash Flow | $-167,269 | $-124,525 | $-94,610 | $195,792 | $120,802 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 804 | 578 | 295 | 2,399 | 2,012 |
| Common Stock Repurchased | 0 | -6,195 | -3,583 | -312,279 | -245,176 |
| Other Financing Activity | -11,907 | 0 | 0 | 0 | -10,389 |
| Financing Cash Flow | $-11,103 | $-5,617 | $-3,288 | $-309,880 | $-253,553 |
| Exchange Rate Effect | 49 | 52 | 15 | 1 | -6 |
| Beginning Cash Position | 162,314 | 162,314 | 162,314 | 97,296 | 97,296 |
| End Cash Position | 139,980 | 137,542 | 114,239 | 162,314 | 91,480 |
| Net Cash Flow | $-22,334 | $-24,772 | $-48,075 | $65,018 | $-5,816 |
| Free Cash Flow | |||||
| Operating Cash Flow | 155,989 | 105,318 | 49,808 | 179,105 | 126,941 |
| Capital Expenditure | -12,796 | -8,112 | -2,843 | -5,405 | -3,510 |
| Free Cash Flow | 143,193 | 97,206 | 46,965 | 173,700 | 123,431 |